Connect with us

Health

FDA Approves Emergency Use of Nation’s First Drug Treatment Against COVID-19

Published

on

FDA Approves Emergency Use

FDA Approves Emergency Use of Nation’s First Drug Treatment Against COVID-19

Photo by Gilead Sciences Inc.

This week, the US Food and Drug Administration (FDA) approved the emergency use of the antiviral remdesivir as the country’s first drug treatment for COVID-19.

The crisis use endorsement (EUA) was given after a legislature supported investigation of 1,063 patients found that hospitalized COVID-19 patients treated with the medication recouped a normal of 4 days quicker than the individuals who were not treated with the medication—a 31% improvement in recuperation time.

The treatment, which was developed by Gilead Sciences Inc., may be approved for expanded use provided that additional research can be conducted on the efficacy and safety of the drug.

The EUA allows for remdesivir to be distributed in the U.S. and administered intravenously by health care providers, as appropriate, to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease. Severe disease is defined as patients with low blood oxygen levels or needing oxygen therapy or more intensive breathing support such as a mechanical ventilator.

“From the very first moment, the FDA has been focused on speeding up the turn of events and accessibility of potential COVID-19 medications. The present activity is a significant advance in our endeavors to work together with trend-setters and specialists to give debilitated patients opportune access to new treatments where fitting, while simultaneously supporting examination to additionally assess whether they are protected and viable,” said FDA Commissioner Stephen M. Hahn.

“There’s tremendous interest among all parties to identify and arm ourselves with medicines to combat COVID-19, and through our Coronavirus Treatment Acceleration Program, the FDA is working around-the-clock and using every tool at our disposal to speed these efforts,” he added.

In view of assessment of the crisis use approval measures and the logical proof accessible, it was resolved that it is sensible to accept that remdesivir might be viable in treating COVID-19, and that, given there are no satisfactory, endorsed, or accessible elective medications, the known and potential advantages to treat this genuine or perilous infection as of now exceed the known and potential dangers of the medication’s utilization.

“The results from the global, placebo-controlled trial run by the National Institute of Allergy and Infectious Diseases (NIAID) are positive. They show that patients with COVID-19 who received remdesivir recovered faster than similar patients who received placebo,” said Gilead Chairman and CEO Daniel O’Day in a statement.

“There is still more work to do and remdesivir has not been affirmed, however we all at Gilead are lowered by what these promising outcomes may mean for patients. Following quite a while of research and difficult work on remdesivir, there is help and appreciation among our groups today that their endeavors have been so advantageous.

“Since January, our teams have been working day and night to determine whether remdesivir might work in patients with COVID-19. These efforts include collaboration with study investigators and governments on the various clinical trials. Today’s news, that remdesivir might play a role in easing the burden of the pandemic, is the outcome we all hoped would be possible.”

Credit:GoodNewsNetwork

Why The Humanity Post?

The World Health Organisation has named depression as the greatest cause of suffering worldwide. In the U.S., 1 out of 5 deals with depression or anxiety. For youth, that number increases to 1 in 3.

The good news is that 40% of our happiness can be influenced by intentional thoughts and actions, leading to life changing habits. It’s this 40% that The Humanity Post  help to impact.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

May is Mental Health Month

Published

on

mental health

May is Mental Health Month, an important opportunity to raise awareness and promote understanding of mental health issues. This year, the theme of Mental Health Month is “Tools 2 Thrive,” which focuses on practical tools and resources that can help individuals improve their mental health and well-being.

Mental health is a critical component of our overall health and well-being, but it is often overlooked or stigmatized. According to the National Alliance on Mental Illness (NAMI), one in five adults in the United States experiences a mental health condition in any given year. Despite the prevalence of these conditions, many people still face barriers to accessing the care and support they need.

One of the key messages of Mental Health Month is that mental health is essential to everyone’s overall health and well-being, and that we all have a role to play in promoting mental health and reducing stigma. This year’s “Tools 2 Thrive” theme focuses on a range of practical tools and resources that individuals can use to improve their mental health and well-being.

Some of the key tools and resources highlighted by NAMI this year include:

  1. Accepting and acknowledging your emotions – This involves recognizing and accepting your feelings, rather than trying to push them away or suppress them. This can help you develop a greater sense of self-awareness and improve your ability to cope with stress and difficult situations.
  2. Connecting with others – Social connections and relationships are important for our mental health and well-being. This can involve reaching out to friends and family, joining a support group, or participating in a community activity.
  3. Creating healthy routines – Developing healthy habits and routines can help promote mental health and well-being. This can include getting enough sleep, eating a balanced diet, and engaging in regular physical activity.
  4. Finding purpose and meaning – Having a sense of purpose and meaning in life can help promote mental health and well-being. This can involve identifying your values and goals, pursuing hobbies and interests, or volunteering in your community.
  5. Seeking professional help – If you are struggling with a mental health condition, it’s important to seek professional help. This can involve talking to your primary care provider, seeking out a mental health professional, or accessing community resources.

In conclusion, Mental Health Month is an important opportunity to raise awareness and promote understanding of mental health issues. By focusing on practical tools and resources that individuals can use to improve their mental health and well-being, we can help reduce stigma and promote a more supportive and inclusive society. Let’s all take steps to prioritize our mental health and support those around us who may be struggling.

Continue Reading

Health

Bill Gates’ Foundation Promise $750M For COVID-19 Vaccine Developed By Oxford Scientists

Published

on

Bill Gates' Foundation Promise $750M For COVID-19

Bill Gates has one again ventured up to help the world battle against COVID-19, this time through his philanthropic endeavor Bill and Melinda Gates Foundation. The tech billionare has poured in $750 million to guarantee the worldwide gracefully of a potential coronavirus immunization being created by British medication creator AstraZeneca.

AstraZeneca is working with scientists from Oxford University for the potential antibody. In spite of the fact that the vaccine is still in the improvement stage, the organization has just dedicated to its large scale manufacturing and accessibility. The thought is to abbreviate the long course of events of vaccine creation.

The new funds will be used to increase the supply of the vaccine globally. With this, the total units of the vaccine available for dispense (once developed) will be more than 2 billion.

Representative Image (Credit:GettyImages)

The Charity Foundations

According to a discharge shared by AstraZeneca this week, the understanding has been made with Coalition of Epidemic Preparedness Innovations (CEPI) established by the Bill and Melinda Gates Foundation, and Gavi, the vaccine partnership.

The $750 million agreement will be used to “support the manufacturing, procurement and distribution of 300 million doses of the potential vaccine, with delivery starting by the end of the year.”

In addition to the agreement with CEPI and Gavi, AstraZeneca has also reached a licensing agreement with Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, to supply one billion doses for low-and-middle-income countries.

Global Distribution

Representative Image (Credit:GettyImages)

AstraZeneca had just reserved 300 million of the potential vaccine to the US and 100 million to the UK. “The Company is building various gracefully chains in equal over the world to help worldwide access at no benefit during the pandemic,” it says.

With the new deal with SII, AstraZeneca has now promised 1 billion doses of the vaccine for low and middle-income countries. Out of these, 400 million will be provided by the end of 2020, the statement confirms. 

The organization had the option to make 1 billion units of the vaccine a month ago. At present, Phase II/III variants of the vaccine are being tried on around 10,000 grown-ups in the UK according to AstraZeneca. On the off chance that its clinical preliminaries end up being fruitful, the primary portions of the vaccine could be prepared by as ahead of schedule as September.

Credit:IndiaTimes

Why The Humanity Post?

The World Health Organisation has named depression as the greatest cause of suffering worldwide. In the U.S., 1 out of 5 deals with depression or anxiety. For youth, that number increases to 1 in 3.

The good news is that 40% of our happiness can be influenced by intentional thoughts and actions, leading to life changing habits. It’s this 40% that The Humanity Post  help to impact.

Continue Reading

Health

New test technique offers more secure measurements of hydroxychloroquine

Published

on

New test technique offers more secure measurements of hydroxychloroquine
Credit:GettyImages

LONDON: Researchers have built up another technique to measure levels of the medication of hydroxychloroquine in patients with the rheumatic infection foundational lupus erythematosus.

The technique developed by specialists at Uppsala University and Uppsala University Hospital in Sweden may likewise be valuable in different regions, for example, in the treatment of Covid-19.

Hydroxychloroquine was originally used to treat malaria but has also proven effective with SLE and rheumatoid arthritis (RA), the researchers said.

Today it is prescribed to all SLE patients since it ensures against flares of the ailment. Tests are currently being led to check whether it can likewise be utilized to treat Covid-19, they said.

A disadvantage of hydroxychloroquine is its side effects which can be avoided, however, if the dosage is adjusted for each patient. To achieve the protective effect against flares in SLE while also minimising the risk of side effects, researchers developed a method that can be used in the medical care system to measure hydroxychloroquine levels in the blood of SLE patients.

The method, described in the journal Arthritis Research and Therapy, is based on high-resolution mass spectrometry.

The researchers went through available data on hydroxychloroquine measurements.

They saw that results from measurements on whole blood, plasma and serum were not comparable with each other.

“It was indicated that there were significant contrasts between various reports, and there appeared to be huge individual contrasts,” said Kim Kultima, Associate Professor at Uppsala University.

They compared the levels of hydroxychloroquine in plasma, serum and whole blood in SLE patients.

The team concluded that the levels in whole blood were about twice as high as in serum and plasma. Whole blood analyses were also the most dependable.

“One striking outcome, and a significant understanding, was that levels in entire blood for patients recommended a similar measurement could vary by up to multiple times between people. This demonstrates a huge individual variety in how the drug is processed,” the specialists said.

One problem pointed out by the study is that the services for electronic information on medicinal products in Sweden (FASS) provides concentrations of hydroxychloroquine in plasma.

The researchers judge that these values provide an inaccurate and inappropriate picture for monitoring medication levels in patients.

“We also have to be very careful about drawing hasty conclusions about whether hydroxychloroquine is effective with Covid-19.

“What we cannot deny is that the examination strategy will ideally prompt better information for giving the correct doses to SLE patients who are endorsed the medicine,” the analysts said.

The team are planning to measure the levels of the medication in the blood of Covid-19 patients if the substance proves effective.

Credit:TimesOfIndia

Why The Humanity Post?

The World Health Organisation has named depression as the greatest cause of suffering worldwide. In the U.S., 1 out of 5 deals with depression or anxiety. For youth, that number increases to 1 in 3.

The good news is that 40% of our happiness can be influenced by intentional thoughts and actions, leading to life changing habits. It’s this 40% that The Humanity Post  help to impact.

Continue Reading

LATEST NEWS

gaza gas gaza gas
Politics7 months ago

Everybody Wants Gaza’s Gas

While its citizens take to the streets demanding a ceasefire, the silence of Europe’s leaders is deafening. Ally-ship runs deep,...

person holding a green plant person holding a green plant
Sustainability1 year ago

Basic sciences for sustainable development challenges and prospects

Basic sciences play a crucial role in sustainable development by providing the foundation for understanding the challenges we face and...

climate change impacts climate change impacts
Environment1 year ago

Climate Change Impacts in Everyday Life

Climate change has a profound impact on everyday life, touching various aspects of our routines and experiences.Climate change has a...

Environmental Sustainability Environmental Sustainability
Environment1 year ago

The Urgency of Environmental Sustainability: Consequences of Failure

In today’s rapidly changing world, environmental sustainability has become a pressing concern. Failing to prioritize and maintain sustainable practices can...

Good Manufacturing Practices Good Manufacturing Practices
Technology1 year ago

Understanding Good Manufacturing Practices (GMP): Guidelines for Quality & Safety

Good Manufacturing Practices (GMP) are a set of guidelines designed to uphold the quality, safety, and efficacy of products manufactured...

internet connection technology display internet connection technology display
Technology1 year ago

How to use ChatGPT? 5 Methods to Earn Money

How to use ChatGPT? ChatGPT, the groundbreaking language model developed by OpenAI, has revolutionized the world of artificial intelligence and...

Gujarat High Court Gujarat High Court
India1 year ago

Gujarat High Court invokes Manusmriti in pregnancy termination matter

The High Court said earlier it was normal for girls to get married between 14 to 16 years and give...

ENTERTAINMENT

Trending

Copyright © 2020 Humanity Post. All rights reserved.